BioCentury | Jul 25, 2020
Product Development

NIH, HHS fast-tracking point-of-care, pooled tech as way out of testing crunch

...units by the fall, and have infrastructure for rapid deployment are eligible for the initiative’s RADx-Advanced Technologies...
BioCentury | Feb 5, 2020
Product Development

Leaner GSK ups R&D investments in immunology, genetics

...the innovative business increasing its R&D investments to focus on immunology, including immuno-oncology, genetics and advanced technologies...
BioCentury | Dec 13, 2019
Product Development

Leveraging real-world data to assess the promise of CAR Ts, Dutch style

...RWE for a long time and how it can be used” for a variety of advanced technologies...
BioCentury | Aug 29, 2019
Company News

Management tracks: Reata, Scholar Rock, Vaccitech, Amunix, Azitra, Ortho Clinical

Chronic and genetic diseases company Reata Pharmaceuticals Inc. (NASDAQ:RETA) hired Manmeet Soni as CFO and EVP, succeeding Jason Wilson, who will become EVP of operations. Soni was CFO of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY). Scholar Rock...
BioCentury | Mar 8, 2019
Targets & Mechanisms

Oral insulin innovation

...Applicator (SOMA) that the group thinks will address many of the problems with the more advanced technologies...
BioCentury | Dec 21, 2018
Company News

GSK, Pfizer JV allows both pharmas to focus on innovation

...an R&D approach focused on science related to the immune system, use of genetics and advanced technologies...
BioCentury | Dec 19, 2018
Company News

GSK, Pfizer JV allows both pharmas to focus on innovation

...an R&D approach focused on science related to the immune system, use of genetics and advanced technologies...
BioCentury | Mar 16, 2018
Financial News

Optum names Witty CEO, launches fund

Andrew Witty will succeed Larry Renfro as CEO of the Optum health services unit of UnitedHealth Group Inc. (NYSE:UNH), effective July 1. Before retiring as CEO of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) last year, Witty advocated...
BioCentury | Mar 13, 2018
Company News

Optum names Witty CEO, launches fund

Andrew Witty will succeed Larry Renfro as CEO of the Optum health services unit of UnitedHealth Group Inc. (NYSE:UNH), effective July 1. Before retiring as CEO of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) last year, Witty advocated...
BioCentury | Feb 17, 2018
Politics, Policy & Law

FDA’s bigger piggy bank

...low-margin products. Payers and consumers are unwilling to pay premiums for products manufactured using more advanced technologies...
Items per page:
1 - 10 of 238
BioCentury | Jul 25, 2020
Product Development

NIH, HHS fast-tracking point-of-care, pooled tech as way out of testing crunch

...units by the fall, and have infrastructure for rapid deployment are eligible for the initiative’s RADx-Advanced Technologies...
BioCentury | Feb 5, 2020
Product Development

Leaner GSK ups R&D investments in immunology, genetics

...the innovative business increasing its R&D investments to focus on immunology, including immuno-oncology, genetics and advanced technologies...
BioCentury | Dec 13, 2019
Product Development

Leveraging real-world data to assess the promise of CAR Ts, Dutch style

...RWE for a long time and how it can be used” for a variety of advanced technologies...
BioCentury | Aug 29, 2019
Company News

Management tracks: Reata, Scholar Rock, Vaccitech, Amunix, Azitra, Ortho Clinical

Chronic and genetic diseases company Reata Pharmaceuticals Inc. (NASDAQ:RETA) hired Manmeet Soni as CFO and EVP, succeeding Jason Wilson, who will become EVP of operations. Soni was CFO of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY). Scholar Rock...
BioCentury | Mar 8, 2019
Targets & Mechanisms

Oral insulin innovation

...Applicator (SOMA) that the group thinks will address many of the problems with the more advanced technologies...
BioCentury | Dec 21, 2018
Company News

GSK, Pfizer JV allows both pharmas to focus on innovation

...an R&D approach focused on science related to the immune system, use of genetics and advanced technologies...
BioCentury | Dec 19, 2018
Company News

GSK, Pfizer JV allows both pharmas to focus on innovation

...an R&D approach focused on science related to the immune system, use of genetics and advanced technologies...
BioCentury | Mar 16, 2018
Financial News

Optum names Witty CEO, launches fund

Andrew Witty will succeed Larry Renfro as CEO of the Optum health services unit of UnitedHealth Group Inc. (NYSE:UNH), effective July 1. Before retiring as CEO of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) last year, Witty advocated...
BioCentury | Mar 13, 2018
Company News

Optum names Witty CEO, launches fund

Andrew Witty will succeed Larry Renfro as CEO of the Optum health services unit of UnitedHealth Group Inc. (NYSE:UNH), effective July 1. Before retiring as CEO of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) last year, Witty advocated...
BioCentury | Feb 17, 2018
Politics, Policy & Law

FDA’s bigger piggy bank

...low-margin products. Payers and consumers are unwilling to pay premiums for products manufactured using more advanced technologies...
Items per page:
1 - 10 of 238